Corporate & Securities Law Community | LexisNexis
Featured Content
  • Add content to My Page

    Select any content type from the list, once selected it will be automatically added to your 'My Page'.


    You are not logged in. Please Login to add content to your community page

03/01/2013 04:17:35 PM EST

Chancellor Strine's View On Disclosures Evolving, Attys Say

Posted by

Law360: Securities

In denying an expedited trial for a shareholder challenge to Allergan Inc.'s $958 million acquisition of MAP Pharmaceuticals Inc. last week, Delaware's top deals judge hinted yet again at a narrowing view on the materiality of certain financial metrics in mergers. Read More...